Matthew Austin

Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial

Jacques P. Brown, Richard L. Prince, Chad Deal et al. · Journal of Bone and Mineral Research · 2008 · 595 citations

Total Hip, Gynecology, Pharmacotherapy +16

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial

Paul D. Miller, Michael A. Bolognese, E. Michael Lewiecki et al. · Bone · 2008 · 562 citations

Bone Disease, Bone Health, Gynecology +9

Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension

Socrates E. Papapoulos, Roland Chapurlat, Cesar Libanati et al. · Journal of Bone and Mineral Research · 2011 · 340 citations · Full text

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

Matthew Austin, Yuching Yang, Eric Vittinghoff et al. · Journal of Bone and Mineral Research · 2011 · 175 citations · Full text

Differing effects of denosumab and alendronate on cortical and trabecular bone

Roger Zebaze, Cesar Libanati, Matthew Austin et al. · Bone · 2013 · 151 citations · Full text